LOGO
LOGO

Quick Facts

Orthofix Medical Q1 Loss Widens, Stock Falls In Pre-Market

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Orthofix Medical Inc. (OFIX), Tuesday announced first-quarter financial results, reporting a net loss of $53.1 million, or $1.35 a share, compared to a net loss of $36.02 million, or $0.95 a share, last year.

On adjusted basis, loss totaled $3.2 million versus a loss of $4.7 million in the prior year.

Net sales for the quarter were $193.6 million compared to $188.6 million in the previous year.

Looking forward, the company anticipates net sales to range between $808 million to $816 million for the full year 2025.

In the pre-market hours, Orthofix's stock is moving down 23.86 percent, to $10.31 on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19